Aytu BioPharma, Inc.
NASDAQ:AYTU
Overview | Financials
Company Name | Aytu BioPharma, Inc. |
Symbol | AYTU |
Currency | USD |
Price | 2.29 |
Market Cap | 14,081,187 |
Dividend Yield | 0% |
52-week-range | 2.11 - 3.49 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Joshua R. Disbrow |
Website | https://aytubio.com |
An error occurred while fetching data.
About Aytu BioPharma, Inc.
Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from 6 years and older; Cotempla XR-ODT for the treatment of
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD